Curexo Inc. (060280.KQ)

KRW 6560.0

(-4.51%)

Revenue Summary of Curexo Inc.

Curexo Inc.'s latest annual revenue in 2023 was 72.88 Billion KRW , up 12.14% from previous year.
Curexo Inc.'s latest quarterly revenue in 2024 Q2 was 13.51 Billion KRW , down -3.08% from previous quarter.
Curexo Inc. reported a annual revenue of 64.99 Billion KRW in annual revenue 2022, up 51.87% from previous year.
Curexo Inc. reported a annual revenue of 42.79 Billion KRW in annual revenue 2021, up 8.94% from previous year.
Curexo Inc. reported a quarterly revenue of 13.51 Billion KRW for 2024 Q2, down -3.08% from previous quarter.
Curexo Inc. reported a quarterly revenue of 19.52 Billion KRW for 2023 Q1, up 7.84% from previous quarter.

Annual Revenue Chart of Curexo Inc. (2023 - 2016)

Historical Annual Revenue of Curexo Inc. (2023 - 2016)

Year	Revenue	Revenue Growth
2023	72.88 Billion KRW	12.14%
2022	64.99 Billion KRW	51.87%
2021	42.79 Billion KRW	8.94%
2020	39.28 Billion KRW	14.23%
2019	34.38 Billion KRW	1.47%
2018	33.88 Billion KRW	1.21%
2017	33.48 Billion KRW	11.39%
2016	30.06 Billion KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q1	13.94 Billion KRW	-18.65%
2024 Q2	13.51 Billion KRW	-3.08%
2023 Q1	19.52 Billion KRW	7.84%
2023 Q2	19.77 Billion KRW	1.31%
2023 Q3	16.44 Billion KRW	-16.88%
2023 Q4	17.13 Billion KRW	4.25%
2023 FY	72.88 Billion KRW	12.14%
2022 Q2	15.3 Billion KRW	4.0%
2022 FY	64.99 Billion KRW	51.87%
2022 Q4	18.1 Billion KRW	7.35%
2022 Q3	16.86 Billion KRW	10.18%
2022 Q1	14.71 Billion KRW	-2.04%
2021 FY	42.79 Billion KRW	8.94%
2021 Q4	15.02 Billion KRW	45.7%
2021 Q3	10.31 Billion KRW	0.0%
2020 FY	39.28 Billion KRW	14.23%
2019 FY	34.38 Billion KRW	1.47%
2018 FY	33.88 Billion KRW	1.21%
2017 FY	33.48 Billion KRW	11.39%
2016 FY	30.06 Billion KRW	0.0%

Peer Revenue Comparison of Curexo Inc.

Name	Revenue	Revenue Difference
Osang Healthcare Co.,Ltd	355.84 Billion KRW	79.519%
InBody Co.,Ltd	170.35 Billion KRW	57.217%
Seegene, Inc.	367.37 Billion KRW	80.161%
i-SENS, Inc.	265.12 Billion KRW	72.51%
Ray Co., Ltd.	145.88 Billion KRW	50.04%
Gencurix Inc.	2.6 Billion KRW	-2702.82%
Sugentech Inc.	7.13 Billion KRW	-921.861%
L&C Bio Co., Ltd	68.86 Billion KRW	-5.826%